Pharma industry is providing aid to Haiti: Abbott is contributing $1 million in grant funding and donations of pharmaceutical and nutritional products and Amgen is donating $2 million. Johnson & Johnson immediately shipped large quantities of its products and Lilly and Pfizer are among others providing medicines and financial assistance.
Venture capitalists raised $15.2 billion in 2009, the lowest dollar total in six years and the lowest number of active funds since 1993.
FDA's Cardiovascular and Renal Drugs Advisory Committee will review Bristol-Myers Squibb's kidney transplant rejection prevention drug, belatacept injectable, March 1.
Amag Pharmaceuticals' chronic kidney disease drug Feraheme will post net revenue of $12 million to $13 million in the fourth quarter of 2009. Addressing the J.P. Morgan Healthcare Conference, CEO Brian Pereira added that Amag is advancing its efforts to win approval of Feraheme in other markets and to expand its label to include iron deficiency anemia regardless of underlying cause.
